Published in Biomacromolecules on May 09, 2005
Nanotechnological strategies for engineering complex tissues. Nat Nanotechnol (2010) 3.15
Nanofibers and their applications in tissue engineering. Int J Nanomedicine (2006) 1.80
Biomimetic nanofibrous scaffolds for bone tissue engineering. Biomaterials (2011) 1.63
Electrospun nanofibers for regenerative medicine. Adv Healthc Mater (2011) 1.44
The role of electrospinning in the emerging field of nanomedicine. Curr Pharm Des (2006) 1.28
Bioactive electrospun scaffolds delivering growth factors and genes for tissue engineering applications. Pharm Res (2010) 1.18
Novel multi-sided, microelectrode arrays for implantable neural applications. Biomed Microdevices (2011) 1.05
Polymeric nanofibers in tissue engineering. Tissue Eng Part B Rev (2011) 1.03
An anisotropic nanofiber/microsphere composite with controlled release of biomolecules for fibrous tissue engineering. Biomaterials (2010) 1.00
New directions in nanofibrous scaffolds for soft tissue engineering and regeneration. Expert Rev Med Devices (2009) 1.00
Conductive Core-Sheath Nanofibers and Their Potential Application in Neural Tissue Engineering. Adv Funct Mater (2009) 0.92
Nanomaterials and nanotechnology for skin tissue engineering. Int J Burns Trauma (2012) 0.90
Nanofibrous scaffolds in biomedical applications. Biomater Res (2014) 0.89
Application of electrospun fibers for female reproductive health. Drug Deliv Transl Res (2017) 0.84
Myogenic differentiation of mesenchymal stem cells in a newly developed neurotised AV-loop model. Biomed Res Int (2013) 0.82
Nanofiber-nanorod composites exhibiting light-induced reversible lower critical solution temperature transitions. Nanotechnology (2011) 0.82
Carbon electrode fabrication from pyrolyzed parylene C. Anal Chem (2011) 0.81
Thin-layer hydroxyapatite deposition on a nanofiber surface stimulates mesenchymal stem cell proliferation and their differentiation into osteoblasts. J Biomed Biotechnol (2012) 0.78
Coupling Infusion and Gyration for the Nanoscale Assembly of Functional Polymer Nanofibers Integrated with Genetically Engineered Proteins. Macromol Rapid Commun (2015) 0.77
The fabrication and testing of electrospun silica nanofiber membranes for the detection of proteins. Nanotechnology (2008) 0.76
Epithelial machines of morphogenesis and their potential application in organ assembly and tissue engineering. Biomech Model Mechanobiol (2012) 0.76
Electrospinning: a fascinating method for the preparation of ultrathin fibers. Angew Chem Int Ed Engl (2007) 4.63
In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials (2003) 4.26
Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med (2005) 2.71
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv Drug Deliv Rev (2002) 2.27
Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J Control Release (2003) 2.18
Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev (2009) 1.82
Serious complications following endovascular thoracic aortic stent-graft repair for type B dissection. Eur J Cardiothorac Surg (2007) 1.81
MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res (2011) 1.79
Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials (2010) 1.77
RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Hum Gene Ther (2006) 1.65
Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes. Bioconjug Chem (2006) 1.55
Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjug Chem (2002) 1.55
Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung. Eur J Pharm Biopharm (2010) 1.49
Highly flexible and tough concentric triaxial polystyrene fibers. ACS Appl Mater Interfaces (2014) 1.38
A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes. J Control Release (2006) 1.37
The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells. Lung Cancer (2007) 1.36
The depolymerization of chitosan: effects on physicochemical and biological properties. Int J Pharm (2004) 1.35
Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. Pharm Res (2002) 1.34
PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice. Bioconjug Chem (2005) 1.32
Integrin targeting using RGD-PEI conjugates for in vitro gene transfer. J Gene Med (2003) 1.30
Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharm (2006) 1.27
Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth. J Biol Chem (2002) 1.25
In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes. Toxicol Appl Pharmacol (2009) 1.21
Core-cross-linked polymeric micelles as paclitaxel carriers. Bioconjug Chem (2004) 1.20
Retracted Estradiol rapidly activates Akt via the ErbB2 signaling pathway. Mol Endocrinol (2003) 1.19
Intracellular processing of poly(ethylene imine)/ribozyme complexes can be observed in living cells by using confocal laser scanning microscopy and inhibitor experiments. Pharm Res (2002) 1.19
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm (2004) 1.18
Progress in the field of electrospinning for tissue engineering applications. Adv Mater (2009) 1.14
Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment. J Control Release (2007) 1.13
HMGA2 gene is a promising target for ovarian cancer silencing therapy. Int J Cancer (2008) 1.13
In vitro MR imaging of regulated gene expression. Radiology (2003) 1.12
Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance. Mol Pharm (2009) 1.12
In vivo SPECT and real-time gamma camera imaging of biodistribution and pharmacokinetics of siRNA delivery using an optimized radiolabeling and purification procedure. Bioconjug Chem (2009) 1.12
Star-shaped poly(ethylene glycol)-block-polyethylenimine copolymers enhance DNA condensation of low molecular weight polyethylenimines. Biomacromolecules (2002) 1.11
Early experience with robot-assisted surgery for mediastinal masses. Ann Thorac Surg (2004) 1.11
Biodegradable polymeric nanocarriers for pulmonary drug delivery. Expert Opin Drug Deliv (2008) 1.11
Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone. J Biol Chem (2003) 1.11
Characterization of a homologous series of D,L-lactic acid oligomers; a mechanistic study on the degradation kinetics in vitro. Biomaterials (2003) 1.10
Toxicity pathway focused gene expression profiling of PEI-based polymers for pulmonary applications. Mol Pharm (2010) 1.10
Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery. Biomaterials (2010) 1.09
Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers? Eur J Pharm Sci (2003) 1.08
Galactose-PEI-DNA complexes for targeted gene delivery: degree of substitution affects complex size and transfection efficiency. J Control Release (2003) 1.07
Copolymers of ethylene imine and N-(2-hydroxyethyl)-ethylene imine as tools to study effects of polymer structure on physicochemical and biological properties of DNA complexes. Bioconjug Chem (2002) 1.07
The structure of PEG-modified poly(ethylene imines) influences biodistribution and pharmacokinetics of their complexes with NF-kappaB decoy in mice. Pharm Res (2002) 1.06
Crosslinked nanocarriers based upon poly(ethylene imine) for systemic plasmid delivery: in vitro characterization and in vivo studies in mice. J Control Release (2007) 1.05
PEG grafting of polyethylenimine (PEI) exerts different effects on DNA transfection and siRNA-induced gene targeting efficacy. J Drug Target (2008) 1.04
Triazine dendrimers as nonviral gene delivery systems: effects of molecular structure on biological activity. Bioconjug Chem (2009) 1.03
The fibroblast growth factor-binding protein FGF-BP. Int J Biochem Cell Biol (2005) 1.03
Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells. Bioconjug Chem (2003) 1.03
Electrospun biodegradable nanofiber nonwovens for controlled release of proteins. J Control Release (2008) 1.03
Deposition of nanoparticles in the arterial vessel by porous balloon catheters: localization by confocal laser scanning microscopy and transmission electron microscopy. AAPS PharmSci (2002) 1.02
Triazine dendrimers as nonviral vectors for in vitro and in vivo RNAi: the effects of peripheral groups and core structure on biological activity. Mol Pharm (2010) 1.01
Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. J Gene Med (2010) 1.01
Nanotubes by template wetting: a modular assembly system. Angew Chem Int Ed Engl (2004) 1.01
Nonviral pulmonary delivery of siRNA. Acc Chem Res (2011) 1.01
Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymers. Biomaterials (2005) 1.00
Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin. J Pharm Sci (2006) 0.99
RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo. Neuro Oncol (2011) 0.99
Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings. J Control Release (2006) 0.99
Effect of poly(ethylene imine) molecular weight and pegylation on organ distribution and pharmacokinetics of polyplexes with oligodeoxynucleotides in mice. Drug Metab Dispos (2004) 0.97
Assembly of well-aligned multiwalled carbon nanotubes in confined polyacrylonitrile environments: electrospun composite nanofiber sheets. J Am Chem Soc (2004) 0.97
Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships in vitro. J Control Release (2007) 0.97
Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK. Neoplasia (2009) 0.97
Controlled antibody/(bio-) conjugation of inorganic nanoparticles for targeted delivery. Adv Drug Deliv Rev (2012) 0.96
Novel magnetic iron oxide nanoparticles coated with poly(ethylene imine)-g-poly(ethylene glycol) for potential biomedical application: synthesis, stability, cytotoxicity and MR imaging. Int J Pharm (2011) 0.96
Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model. Int J Pharm (2008) 0.96
Bioreversibly crosslinked polyplexes of PEI and high molecular weight PEG show extended circulation times in vivo. J Control Release (2007) 0.96
Training a sophisticated microsurgical technique: interposition of external jugular vein graft in the common carotid artery in rats. J Vis Exp (2012) 0.95
Computational insights into the interactions between DNA and siRNA with "rigid" and "flexible" triazine dendrimers. Biomacromolecules (2010) 0.95
Polycationic triazine-based dendrimers: effect of peripheral groups on transfection efficiency. New J Chem (2009) 0.95
Functional role and therapeutic potential of the pim-1 kinase in colon carcinoma. Neoplasia (2013) 0.94
Stabilized nanocarriers for plasmids based upon cross-linked poly(ethylene imine). Biomacromolecules (2006) 0.94
Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs. Cancer Chemother Pharmacol (2010) 0.94
Expression and function of the receptor protein tyrosine phosphatase zeta and its ligand pleiotrophin in human astrocytomas. J Neuropathol Exp Neurol (2003) 0.94
Biocompatible and biodegradable polymer nanofibers displaying superparamagnetic properties. Chemphyschem (2005) 0.94
Hydrolytic degradation of poly(lactide-co-glycolide) films: effect of oligomers on degradation rate and crystallinity. Int J Pharm (2003) 0.93
In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymers. Biomaterials (2011) 0.93
The potential of glycol chitosan nanoparticles as carrier for low water soluble drugs. Int J Pharm (2009) 0.92
PEGylation affects cytotoxicity and cell-compatibility of poly(ethylene imine) for lung application: structure-function relationships. Toxicol Appl Pharmacol (2009) 0.92
Electrospinning approaches toward scaffold engineering--a brief overview. Artif Organs (2006) 0.92
Integrin alphaVbeta3 targeted gene delivery using RGD peptidomimetic conjugates with copolymers of PEGylated poly(ethylene imine). Bioconjug Chem (2009) 0.92
Enhancing in vivo circulation and siRNA delivery with biodegradable polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol) copolymers. Biomaterials (2012) 0.92
Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene-induced senescence. EMBO Mol Med (2013) 0.92
Targeting the blind spot of polycationic nanocarrier-based siRNA delivery. ACS Nano (2012) 0.92